STAT
FEBRUARY 26, 2025
The Food and Drug Administration canceled an upcoming vaccine advisory committee meeting to discuss influenza virus strains, according to committee member Paul Offit. The meeting was scheduled for March 13. Committee members received a cancellation email — which was first reported by Jeremy Faust of Inside Medicine — on Wednesday afternoon.
Express Pharma
FEBRUARY 26, 2025
MO Alternate Investment Advisors (MO Alts) has agreed to invest up to INR 460 crores for a majority stake in Mega Fine Pharma (Megafine).The Sanghvi Family, one of the founding-promoter groups, has also participated in this transaction, increasing their stake in the Company. Megafine, established in 1995, is an export-focused Active Pharmaceutical Ingredient (API) company based in Mumbai.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharmacist
FEBRUARY 26, 2025
Guidance for the education and training of pharmacists and pharmacist independent prescribers has been updated to reflect commitments to sustainability, the General Pharmaceutical Council (GPhC) has announced. The updated guidance highlights the crucial role of pharmacists as medicines experts in working towards the more environmentally sustainable use of medicines and decreasing their associated carbon footprint […] The post GPhC updates education and training guidance to support sustaina
European Pharmaceutical Review
FEBRUARY 26, 2025
A study has demonstrated a new approach to prepare tablets for intestinal drug delivery by combining two 3D printing techniques. Using both selective laser sintering (SLS) and fused deposition modelling (FDM), the technique has potential to achieve delayed and prolonged drug release, according to the findings. Key findings from the 3D printing drug delivery study [a] laser speed of 90 mm s1 was suitable for producing [3D printed tablet] cores with relatively short disintegration time and suffici
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Express Pharma
FEBRUARY 26, 2025
Dr Reddys Laboratories has recently announced that it has received the Establishment Inspection Report (EIR) from the United States Food & Drug Administration (USFDA) for its Active Pharmaceutical Ingredient (API) manufacturing facility (CTO-2) in Bollaram, Hyderabad. The update follows the companys earlier intimation on November 19, 2024 regarding the USFDA inspection at the facility.
Pharma Times
FEBRUARY 26, 2025
Updated data from phase 2 study reveals survival benefit
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
FDA Law Blog: Biosimilars
FEBRUARY 26, 2025
By John W.M. Claud The ongoing DOGE-led reductions to the federal workforce and recent sweeping policy changes have spawned many questions for compliance officers and quality managers in FDA-regulated companies. How will the cuts at FDA impact inspections and enforcement? Will there be a heightened appetite for mergers and acquisitions in the space?
Drug Channels
FEBRUARY 26, 2025
On March 18, 2025, Drug Channels Institute will release The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. This reportour sixteenth editionremains the most comprehensive, fact-based tool for understanding the entire U.S. drug pricing, reimbursement, and dispensing system. This unique, encyclopedic resource is your ultimate guide to the complex web of interactions within U.S. prescription drug channels. 12 chapters, 500+ pages, 267 exhibits, nearly 1,200 endnotes: There is
Pharma Times
FEBRUARY 26, 2025
Data presented in Los Angeles showcases therapys potential
Drug Patent Watch
FEBRUARY 26, 2025
The Complex World of Biologic Drugs: Navigating Patent Applications As a biotech professional, you're likely no stranger to the intricacies of developing life-changing treatments. But have you ever stopped to think about the patent landscape surrounding biologic drugs? It's a complex world, to say the least. Biologic drugs, also known as biologics, are a type of medication made from living organisms or their components.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
FEBRUARY 26, 2025
Explore how gamification and innovative technologies can revolutionise medical education, making learning more engaging and effective. Discover the benefits and best practices for integrating gamification into medical training.
Pharmaceutical Technology
FEBRUARY 26, 2025
Eikons lead candidate EIK1001 is being investigated for melanoma in combination with MSDs Keytruda in a Phase III trial.
pharmaphorum
FEBRUARY 26, 2025
Explore the current state and achievements of women in science with insights from Michelle Bridenbaker, Alexandra Tabbitt, Agnes Cwienczek, Jean Redmond, Dr Jessica Steier, and Sabine Glden. Learn about their contributions and the progress being made in the field.
BioPharma Dive
FEBRUARY 26, 2025
The funding comes as Eikon, run by former Merck research chief Roger Perlmutter, has started a Phase 3 trial testing one of its cancer drugs against Keytruda.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
pharmaphorum
FEBRUARY 26, 2025
Bayer is close to filing a new MRI contrast agent that can reduce levels of gadolinium, which can have health and environmental consequences.
The Pharmacist
FEBRUARY 26, 2025
The government has made limited progress in achieving its vision of containing antimicrobial resistance (AMR), the public spending watchdog has warned. The National Audit Office (NAO)investigated AMRin light of it being a serious public health threat and after the Covid-19pandemic showed that the UK was not as resilient to such threats asitexpected tobe.
pharmaphorum
FEBRUARY 26, 2025
The FDA is set to decide on MSD's Keytruda as perioperative treatment of locally advanced head and neck squamous cell carcinoma in June
BioPharma Dive
FEBRUARY 26, 2025
While announcing billions of dollars in new U.S. investments, company chief David Ricks called for an extension of 2017 tax cuts and changes to Medicare's drug negotiation program.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Drug Patent Watch
FEBRUARY 26, 2025
Unlocking the Secrets to Patenting Drug Combinations: Strategies and Challenges As a pharmaceutical professional, you know how crucial it is to stay ahead of the curve when it comes to patenting innovative treatments. One area that's gaining significant attention is drug combinations pairing two or more active ingredients to create a more effective therapy.
BioPharma Dive
FEBRUARY 26, 2025
The British drugmaker claimed study success in a first-line setting in breast cancer. Elsewhere, Rezdiffra sales continued to grow and a cancer biotech cut staff.
pharmaphorum
FEBRUARY 26, 2025
Eikon has added to its already copious cash reserves with a $351m round for its expanding pipeline of cancer therapies.
Pharmaceutical Technology
FEBRUARY 26, 2025
The Phase III trial met the primary and secondary endpoints of reducing tics in children and adult patients with Tourette syndrome.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
pharmaphorum
FEBRUARY 26, 2025
AstraZeneca could be the first to bring an oral SERD to market in first-line breast cancer after camizestrant hit the mark in a phase 3 trial.
Pharmaceutical Technology
FEBRUARY 26, 2025
With a potential buyer not working out, Idorsia has adjusted an existing partnership and restructured bonds to raise cash.
pharmaphorum
FEBRUARY 26, 2025
A clinical trial has found that a continuous glucose monitor device systemically overestimated blood glucose levels when used by non-diabetic people.
Pharmaceutical Technology
FEBRUARY 26, 2025
RedHill has signed an exclusive licensing agreement with Hyloris for the global development and commercialisation of RHB-102 (Bekinda).
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmaTech
FEBRUARY 26, 2025
Webinar Date/Time: Fri, Mar 21, 2025 11:00 AM EDT
Pharmaceutical Technology
FEBRUARY 26, 2025
The US Food and Drug Administration (FDA) approved 126 innovator and biosimilar drugs in 2024, significantly lower than the 149 approvals in 2023.
Pharmacy Joe
FEBRUARY 26, 2025
In this episode, I’ll discuss oral sedation strategies for young patients presenting to the ED with acute severe behavioral disturbance. Episode 1004: An Example of a Study Where the Forest is More Important Than the Trees Subscribe on iTunes , Android , or Stitcher When treating children and adolescents who present to the ED with acute behavioral disturbances, the American Association for Emergency Psychiatry states: There is consensus that PO administration should be tried whenever possi
Pharmaceutical Technology
FEBRUARY 26, 2025
Organovos lead asset FXR314 will be investigated in a Phase II trial for inflammatory bowel disease (IBD).
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert insights. Personalized for you.
363 
Let's personalize your content